Statistics for Abeona Therapeutics (id:5769 ABEO)

Valuation metrics

Market cap

259.96M

Enterprise value

158.18M

Trailing P/E (ttm)

-2.36

Forward P/E

-4.04

PEG ratio

-4.04

Price/Sales (ttm)

74.27

Price/Book (mrq)

10.70

Enterprise Value/Revenue

45.19

Enterprise Value/EBITDA

-2.89

Overview

Shares outstanding

43.47M

Float

28.01M

Shares short

2.64M

% Held by insiders

0.05%

% Held by institutions

0.78%

Average volume (10 days)

435.46K

Average volume (90 days)

Price summary

52-Week low

3.05

52-Week high

9.01

52-Week change

27.93%

Beta

1.50

50-Day moving average

6.19

200-Day moving average

5.76

Dividends and splits

Forward annual dividend rate

593.00

Forward annual dividend yield

99.16

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

March 31th, 2000

Last split factor

2:1

Last split date

July 05th, 2022

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

54.14%

Operating margin

-1,536.29%

Operational effectiveness

Return on assets

-37.81%

Return on equity

-127.38%

Income statement

Revenue (ttm)

0.16

Revenue per share (ttm)

0.16

Quarterly revenue growth (yoy)

Gross profit (ttm)

1.90M

EBITDA

-54,747,000.00

Net income to common (ttm)

-52,599,000.00

Diluted EPS (ttm)

-2.05

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

122.71M

Total cash per share (mrq)

2.83

Total debt (mrq)

23.16M

Total Debt/Equity (mrq)

31.63

Current ratio (mrq)

747.50%

Book value per share (mrq)

0.56

Cash flow

Cash flow statement

-42,203,000.00

Levered free cash flow (LFCF)

-20,499,376.00